| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $339,344 | +12,412 | +15% | $27.34 | 95,408 | 23 Feb 2024 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $23,846 | -859 | -0.9% | $27.76 | 94,549 | 23 Feb 2024 | Direct | F2 |
| transaction | PFE | Common Stock | Tax liability | $274,548 | -10,031 | -11% | $27.37 | 84,518 | 23 Feb 2024 | Direct | F3, F4 |
| transaction | PFE | Common Stock | Tax liability | $83,058 | -2,992 | -3.5% | $27.76 | 81,526 | 25 Feb 2024 | Direct | F5, F6 |
| transaction | PFE | Common Stock | Tax liability | $164,792 | -6,063 | -7.4% | $27.18 | 75,463 | 26 Feb 2024 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -12,412 | -100% | $0.000000* | 0 | 23 Feb 2024 | Common Stock | 12,412 | $27.34 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| F5 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| F6 | Price is the closing price of Pfizer common stock on February 23, 2024. |
| F7 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |